🇺🇸 FDA
Pipeline program

Trulicity 0.75 mg solution for injection in pre-filled pen

Phase 3 small_molecule active

Quick answer

Trulicity 0.75 mg solution for injection in pre-filled pen for Metabolic syndrome in patients on the waiting list for kidney transplantation, Metabolic syndrome in patients on the waiting list for kidney transplantation is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
Metabolic syndrome in patients on the waiting list for kidney transplantation, Metabolic syndrome in patients on the waiting list for kidney transplantation
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials